Trial Opens In Glaxo's Lamictal Patent Suit
U.K. drug maker GlaxoSmithKline Plc's patent lawsuit against Israeli generics maker Teva Pharmaceutical Industries Ltd. over its best-selling anti-epileptic drug Lamictal will be heard in a U.S. court on Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article